Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages ; volume:15 ; number:1 ; day:18 ; month:11 ; year:2014 ; pages:1-13 ; date:12.2014
BMC genomics ; 15, Heft 1 (18.11.2014), 1-13, 12.2014
- Urheber
-
Kaushik, Swati
- Beteiligte Personen und Organisationen
-
Sowdhamini, Ramanathan
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-15-985
- URN
-
urn:nbn:de:1111-2016072857264
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaushik, Swati
- Sowdhamini, Ramanathan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Modeling of motion primitive architectures using domain-specific languages
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Modeling of motion primitive architectures using domain-specific languages
Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
Genome-wide survey of prokaryotic serine proteases: Analysis of distribution and domain architectures of five serine protease families in prokaryotes
Modulation of prolyl hydroxylase domain (PHD) 2 in tumor inflammation
Prokaryotic genomics
Capturing protein domain structure and function using self-supervision on domain architectures
Prokaryotic toxin-antitoxins
Comparative genomics reveals selective distribution and domain organization of FYVE and PX domain proteins across eukaryotic lineages
Prolyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancer
Dynamic control of the prolyl isomerase function of the dual-domain SlyD protein
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2